These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2888108)

  • 21. Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response.
    Jäger M; Riedel M; Schmauss M; Pfeiffer H; Laux G; Naber D; Gaebel W; Huff W; Schmidt LG; Heuser I; Buchkremer G; Kühn KU; Rüther E; Hoff P; Gastpar M; Bottlender R; Strauss A; Möller HJ
    Psychiatry Res; 2008 Apr; 158(3):297-305. PubMed ID: 18280582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How to distinguish between the neuroleptic-induced deficit syndrome, depression and disease-related negative symptoms in schizophrenia.
    Barnes TR; McPhillips MA
    Int Clin Psychopharmacol; 1995 Sep; 10 Suppl 3():115-21. PubMed ID: 8866773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pimozide treatment of the negative schizophrenic syndrome: an open trial.
    Feinberg SS; Kay SR; Elijovich LR; Fiszbein A; Opler LA
    J Clin Psychiatry; 1988 Jun; 49(6):235-8. PubMed ID: 3288615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of subjective well-being in schizophrenic patients with gait parameters, expert-rated motor disturbances, and psychopathological status.
    Putzhammer A; Perfahl M; Pfeiff L; Hajak G
    Pharmacopsychiatry; 2005 May; 38(3):132-8. PubMed ID: 15902585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: effects of typical neuroleptics on the brief psychiatric rating scale.
    Harvey PD; Davidson M; White L; Keefe RS; Hirschowitz J; Mohs RC; Davis KL
    Biol Psychiatry; 1996 Oct; 40(8):755-60. PubMed ID: 8894068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Psychopathology of schizophrenia and brain imaging].
    Gross G; Huber G
    Fortschr Neurol Psychiatr; 2008 May; 76 Suppl 1():S49-56. PubMed ID: 18461545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of the positive-negative distinction in schizophrenia.
    Kay SR
    Schizophr Bull; 1990; 16(4):635-52. PubMed ID: 2077641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Syndrome and symptom development in long-term follow-up of schizophrenia].
    Franzek E; Beckmann H
    Nervenarzt; 1991 Sep; 62(9):549-56. PubMed ID: 1956474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The positive-negative distinction in drug-free schizophrenic patients. Stability, response to neuroleptics, and prognostic significance.
    Kay SR; Singh MM
    Arch Gen Psychiatry; 1989 Aug; 46(8):711-8. PubMed ID: 2568824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The predictive value of psychopathological subclassifications for the neuroleptic treatment outcome in schizophrenia.
    Jarema M; Kacperczyk J; Kruszynski S
    Psychopathology; 1991; 24(3):141-6. PubMed ID: 1684443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relation of familial schizophrenia to negative symptoms but not to the deficit syndrome.
    Malaspina D; Goetz RR; Yale S; Berman A; Friedman JH; Tremeau F; Printz D; Amador X; Johnson J; Brown A; Gorman JM
    Am J Psychiatry; 2000 Jun; 157(6):994-1003. PubMed ID: 10831482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positive and negative syndromes in chronic schizophrenic inpatients.
    Opler LA; Kay SR; Rosado V; Lindenmayer JP
    J Nerv Ment Dis; 1984 Jun; 172(6):317-25. PubMed ID: 6152720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic significance of negative symptoms in schizophrenia.
    Pogue-Geile MF
    Br J Psychiatry Suppl; 1989 Nov; (7):123-7. PubMed ID: 2695134
    [No Abstract]   [Full Text] [Related]  

  • 34. Deficit symptoms in schizophrenia: negative symptoms versus neuroleptic-induced deficits.
    Schooler NR
    Acta Psychiatr Scand Suppl; 1994; 380():21-6. PubMed ID: 7914043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Definition, significance and measurement of disease concepts of patients. The Disease Concept Scale for schizophrenic patients].
    Linden M; Nather J; Wilms HU
    Fortschr Neurol Psychiatr; 1988 Feb; 56(2):35-43. PubMed ID: 2896142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positive and negative syndromes in schizophrenia as a function of chronicity.
    Kay SR; Fiszbein A; Lindenmayer JP; Opler LA
    Acta Psychiatr Scand; 1986 Nov; 74(5):507-18. PubMed ID: 3492863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The positive and negative syndrome scale (PANSS) for schizophrenia.
    Kay SR; Fiszbein A; Opler LA
    Schizophr Bull; 1987; 13(2):261-76. PubMed ID: 3616518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evolution of the schizophrenic deficit concept].
    Smulevich AB; Romanov DV; Voronova EI; Mukhorina AK; Chitlova VV; Sorokina OY
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):4-14. PubMed ID: 29053114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reliability and validity of the positive and negative syndrome scale for schizophrenics.
    Kay SR; Opler LA; Lindenmayer JP
    Psychiatry Res; 1988 Jan; 23(1):99-110. PubMed ID: 3363019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The concept of negative symptoms.
    Wing JK
    Br J Psychiatry Suppl; 1989 Nov; (7):10-4. PubMed ID: 2695132
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.